期刊文献+

特发性血小板减少性紫癜患者外周血CD1d^((hi))CD5^+CD19^+调节性B细胞的变化及意义 被引量:2

Changes of CD1d^((hi))CD5^+CD19^+ regulatory B cells in peripheral blood of patients with idiopathic thrombocytopenic purpura and its significance
下载PDF
导出
摘要 目的研究特发性血小板减少性紫癜(ITP)患者外周血中调节性B细胞(regulatory B cells,Breg)亚群和相关细胞因子的变化及其相关性,探讨Breg在ITP发病机制中的作用。方法选择30例ITP患者,分离外周血单个核细胞(PBMC),用流式细胞术(FCM)检测CD19+B、CD5+CD19+B、CD1d(hi)CD5+CD19+B细胞亚群的比例变化;用ELISA法测定PBMC培养液上清中白细胞介素-10(IL-10)及转化生长因子-β1(TGF-β1)水平,与同期选择的健康人对照组比较。结果与对照组相比,ITP患者外周血中CD19+B、CD5+CD19+B细胞亚群的比例均升高,而CD1d(hi)CD5+CD19+Breg的比例降低,差异均有统计学意义(P<0.05)。ITP患者PBMC培养液上清IL-10、TGF-β1的水平低于健康人对照组(P<0.05)。患者Breg的比例与IL-10表达水平呈正相关(r=0.717,P<0.05),而与TGF-β1水平无相关性(r=0.073,P>0.05)。结论 CD1d(hi)CD5+CD19+Breg及相关细胞因子IL-10的下调可能参与ITP的免疫调节紊乱机制。 Objective To study the changes of regulatory B cells(Breg) subsets in peripheral blood of patients with idiopathic thrombocytopenic purpura(ITP) and related cytokines,analyze their correlation and explore the role of Breg in the pathogenesis of ITP.Methods The proportional changes of CD19+B,CD5+CD19+B and CD1d(hi)CD5+CD19+B subsets in peripheral blood were determined by flow cytometry(FCM) and the levels of IL-10 and TGF-β1 in the supernatant of culture medium of peripheral blood mononuclear cells(PBMC) were measured by ELISA in 30 patients with ITP and 30 matching healthy controls.Results Compared to normal controls,the proportions of CD19+B,CD5+CD19+B subset were increased,but the proportion of CD1d(hi)CD5+CD19+B subset was decreased,and there were statistically significant differences(P&lt;0.05).The expression levels of IL-10 and TGF-β1 in culture medium of PBMC of ITP patients were lower than those in healthy controls(P&lt;0.05).There was a positive correlation between the proportion of CD1d(hi)CD5+CD19+B subsets and the levels of IL-10(r=0.717,P&lt;0.05),but there was no correlation between CD1d(hi)CD5+CD19+B subsets and the levels of TGF-β1(r=0.073,P&gt;0.05).Conclusion The low expression of CD1d(hi)CD5+CD19+B subsets and related cytokines IL-10 may participate in the mechanism of immunoregulative dysfunction in ITP patients.
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第3期181-183,共3页 Chinese Journal of Clinical Laboratory Science
基金 广东省深圳市科技计划项目(201202053)
关键词 特发性血小板减少性紫癜 调节性B细胞 白细胞介素-10 转化生长因子 idiopathic thrombocytopenic purpura regulatory B cells IL-10 TGF-β1
  • 相关文献

参考文献9

  • 1Nishimoto T, Satoh T, Takeuchi T, et al. Critical role of CD4^+ CD25^+ regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia[J]. Exp Hematol,2012,40(g) :279-289.
  • 2Hu Y, Ma DX, Shan NN, et al. Increased number of Te17 and correlation with Th17 cells in patients with immune thrombocytopenia [J]. PLoS One,2011,6(10) :e26522.
  • 3Wu CL, Xu JC, Li F, et al. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura[ J]. Int J Lab Hematol, 2007,29(3) :177-184.
  • 4Lee JH, Noh J, Noh G, et al. Allergen-specific transforming growth factor-β-producing CD19^+ CD5^+ regulatory B-cell ( Br3 ) responses in human late eczematous allergic reactions to cow's milk[ J]. J Interferon Cytokine Res, 2011,31 ( 5 ) :441-449.
  • 5Knippenberg S, Peelen E, Smolders J, et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission [J]. J Neuroimmunol,2011,239(1-2) :80-86.
  • 6Inoue S, Leitner WW, Golding B, et al. Inhibitory effects of B cells on antitumor immunity [ J ]. Cancer Res, 2006, 66 ( 15 ) : 7741-7747.
  • 7Noh G, Lee JH. Regulatory B cells and allergic diseases [ J ]. Allergy Asthma Immunol Res, 2011, 3(3) : 168-177.
  • 8Noh J, Choi WS, Noh G, et al. Presence of Foxp3-expressing CD19^+ CD5^+B cells in human peripheral blood mononuclear cells: human CD19^+CD5^+ Foxp3^+ regulatory B cell (Breg) [J]. Immune Netw, 2010,10(6) :247-249.
  • 9Lo-Man R. Regulatory B cells control dendritic cell functions [ J ]. Immunotherapy, 2011, 3 (4 Suppl) : 19-20.

同被引文献29

  • 1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 2Siewe B, Stapleton JT, Martinson J, etal. Regulatory B cell fre- quency correlates with markers of HIV disease progression and attenuates anti HIV CD8+ T cell function in vitro[J]. J Leukoc Bi ol, 2013, 93(5):811-818.
  • 3Okkenhaug K, Bilancio A, Farjot G, et al. Impaired B and T cell antigen receptor signaling in pll0 PI 3-kinase mutant mice[J]. Science, 2002, 297(5583):1031-1034.
  • 4Mizoguchi A, Mizoguchi E, Smith NR, etal. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice[J]. J Exp Med, 1997, 186(10):1749-1756.
  • 5Lane HC, Masur H, Edgar LC, etal. Abnormalities of B cell ac- tivation and immunoregulation in patients with the acquired im- munodeficiency syndrome [J]. N Engl J Med, 1983, 309(8) :453 -458.
  • 6Hussain S, Delovitch TL. Intravenous transfusion of BCR-activa- ted B cells protects NOD mice from type 1 diabetes in an IL-10-de- pendent manner[J]. J Immunol, 2007, 179(11):7225-7232.
  • 7Haas KM, Watanabe R, Matsushita T, et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice[J]. J Immunol, 2010, 184(9) :4789-4800.
  • 8Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppres- sive function of transitional 2 B cells in experimentalarthritis[J]. J Immunol, 2007, 178(12):7868 -7878.
  • 9Fillatreau S. Cytokine-producing B cells as regulators of patho- genic and protective immune responses[J]. Ann Rheum Dis, 2013, 72 (2):80-84.
  • 10Noh J, Choi WS, Noh G, et al. Presence of Poxp3-expresssion CD19+ CD5+ B cells in human peripheral blood mononuclear cells, human CD19+ CD5+ Foxp3+ regulatory B cell (Breg) [J]. Im- mune Netw, 2010, 10(6),247-249.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部